Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

standard quadruple antiemetic therapy

Phase 3

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[2][1]

Indication

Standard Quadruple Antiemetic TherapyRecruiting

Standard Quadruple Antiemetic TherapyPhase 3

Recruiting

Timeline

Expected Milestones

Q2 2028

Phase 3Recruiting

Standard Quadruple Antiemetic Therapy

NCT06952920

Clinical

Trials by Indication[1]

Standard Quadruple Antiemetic Therapy1 trial

Electroacupuncture for Managing Chemotherapy-Induced Gastrointestinal Symptom Clusters in Patients With Breast Cancer

Recruiting·JJiuda Zhao·Phase 3·NCT06952920·388 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for standard quadruple antiemetic therapy. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for standard quadruple antiemetic therapy. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Jiuda Zhao company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Phase 3[1]
Company: JJiuda Zhao

Related News